Utilizing targeted cancer therapeutic agents in combination: novel approaches and urgent requirements von Doroshow, James H, Kummar, Shivanni, Chen, Helen X, Wright, John, Holbeck, Susan, Millin, Myrtle Davis, Tomaszewski, Joseph, Zweibel, James, Collins, Jerry

Volltext

Discovery of Potent Myeloid Cell Leukemia‑1 (Mcl-1) Inhibitors That Demonstrate in Vivo Activity in Mouse Xenograft Models of Human Cancer von Lee, Taekyu, Christov, Plamen P, Shaw, Subrata, Tarr, James C, Zhao, Bin, Veerasamy, Nagarathanam, Jeon, Kyu Ok, Mills, Jonathan J, Bian, Zhiguo, Sensintaffar, John L, Arnold, Allison L, Fogarty, Stuart A, Perry, Evan, Ramsey, Haley E, Cook, Rebecca S, Hollingshead, Melinda, Davis Millin, Myrtle, Lee, Kyung-min, Koss, Brian, Budhraja, Amit, Opferman, Joseph T, Kim, Kwangho, Arteaga, Carlos L, Moore, William J, Olejniczak, Edward T, Savona, Michael R, Fesik, Stephen W

Volltext

BAX-BAK heterodimer as a pharmacodynamic biomarker of on-target drug action of Mcl-1 inhibitors to evaluate in-vivo effectiveness von Srivastava, Apurva K., Govindharajulu, Jeevan P, Hollingshead, Melinda G., Moore, William J, Tomaino, Francesca, Banfield, Kelly, Lee, Taekyu, Olejniczak, Edward T, Sensintaffar, John, Millin, Myrtle Davis, Parchment, Ralph E., Doroshow, James H., Fesik, Stephen

Volltext

Analyses of the combination of 6-MP and dasatinib in cell culture von KAUR, GURMEET, BEHRSING, HOLGER, PARCHMENT, RALPH E, MILLIN, MYRTLE DAVIS, TEICHER, BEVERLY A

Volltext

Abstract 1303: Characterization of the metabolite profile for batracylin and N-acetylbatracylin in rat and human models of invitro and in vivo metabolism: Elucidation of pathways t... von Ames, Matthew M., Reid, Joel M., Buhrow, Sarah A., Kuffel, Mary J., Walden, Chad A., Covey, Joseph M., Behrsing, Holger P., Millin, Myrtle Davis

Volltext